Macrophage responses are skewed toward a phenotype that produces less proinflammatory TNFα and profibrotic TGFβ, thereby is less able to support NAFLD development and progression to NASH (Dey et al., 2014). Here, TGFB1 is linked to metabolic dysfunction-associated steatotic liver disease.